FINAL WEEK to apply for more than $1 million in award funding! Let us fund your CGT research; apply through Aug. 1.
Editors from the Molecular Therapy Family of Journals profile impactful research published in ASGCT's journals.
Find insightful intervews, riviting conversations, and incredible discoveries on the ASGCT Podcast Network.
Drs. Paloma Giangrande and Marcin Kortylewski discuss a recent article published in Molecular Therapy Nucleic Acids by Dr. Kortylewski and colleagues titled "Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3."
Dr. Daniel Stone speaks with Drs. Mario Mietzsch and Robert McKenna from the University of Florida to discuss their recent article published in MTMCD's recent special issue Biomanufacturing in Gene and Cell Therapy titled "Production and characterization of an AAV1-VP3-only capsid: An analytical benchmark standard."
Mohamed Abou-el-Enein, MD, PhD, MSPH, the new editor-in-chief of Molecular Therapy Methods & Clinical Development (MTMCD), sits down with Scientific Editor Rory Bricker-Anthony, PhD, to discuss his vision for the journal.
Dr. Norbert Pardi discusses a recent article published in the September issue of Molecular Therapy by Dr. Pardi and colleagues titled, "Development of an mRNA-lipid Nanoparticle Vaccine Against Lyme Disease."
Dr. Richard Vile discusses an article published in the June issue of Molecular Therapy Oncology by himself and colleagues titled, "Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses."
Dr. Maxim Berezovski discusses a recent article he and colleagues published in Molecular Therapy Nucleic Acids, Discovery of DNA aptamers targeting SARS-CoV-2 nucleocapsid protein and protein-binding epitopes for label-free COVID-19 diagnostics.
Drs. David Schaffer and Adam Schieferecke discuss a recent article they published with colleagues in the February issue of Molecular Therapy titled, "Evolving membrane-associated accessory protein variants for improved adeno-associated virus production."
Join Drs. Timothy Cripe and Marco Davila as they discuss a recent article published in the December issue of Molecular Therapy Oncology by Dr. Davila and colleagues titled, Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia.
September 23-24, 2024 | Washington, D.C.
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico